EUVIMEDEUVIMED entdecken
Crossref

Significance of Portal Tract Histological Changes in Metabolic Dysfunction-Associated Steatohepatitis

A Rastogi, N Nagar, C Bihari, N Agrawal, R Maiwal

Acta Gastro-Enterologica Belgica · 2026

DOI: 10.51821/89.3.15672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Gastro-Enterologica Belgica, 2026. Verfasst von A Rastogi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, Delhi, India-110070. Hauptthemen laut MEDLINE: Liver Cirrhosis, Liver, Portal System, Fatty Liver.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction associated steatohepatitis (MASH) is a leading cause of advanced liver fibrosis globally. Current histological scoring (NAS-CRN) excludes portal-based features, despite emerging evidence suggesting their relevance.

Aim

To study the prevalence of portal tract changes and their correlation with fibrosis in liver biopsies from patients with MASH.

Methods

In this retrospective and prospective cross-sectional study, 505 liver biopsies were analysed. Portal inflammation, interface hepatitis, ductular reaction, bile duct damage, and plasma cells were semi-quantitatively assessed. Fibrosis was quantified using whole slide digital images of Sirius red-stained slides, and hepatic progenitor cells (HPC) were measured by CK7 immunohistochemistry.

Results

Mean age was 45.1±12.5 years, with 65% males. Advanced fibrosis (F3–F4) was present in 69.1%. Portal inflammation was observed in 69.3% (predominantly mild). Moderate–severe portal inflammation, plasma cells, interface activity, ductular reaction, duct damage, and HPC were significantly associated with advanced fibrosis (all p≤0.005). Portal inflammation significantly correlated with ductular reaction, interface activity, plasma cell infiltration, bile duct damage, progenitor cells, and fibrosis fraction (all p≤0.005).

Conclusion

Portal inflammation and related features are strongly associated with advanced fibrosis in MASH, thereby suggesting multifactorial role in disease progression and supporting their inclusion in histological scoring systems and routine reporting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisLiverPortal SystemFatty LiverHumansMaleMiddle AgedCross-Sectional StudiesFemaleRetrospective StudiesAdultProspective StudiesBiopsyDisease Progression

Stichwörter der Autor:innen

Metabolic dysfunction-associated steatohepatitisfibrosishistological scoringportal featuresportal inflammationquantification

Autor:innen und Institutionen

  • Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, Delhi, India-110070.

Zitieren

APA

Rastogi, A., Nagar, N., Bihari, C., Agrawal, N., & Maiwal, R. (2026). Significance of Portal Tract Histological Changes in Metabolic Dysfunction-Associated Steatohepatitis. Acta Gastro-Enterologica Belgica. https://doi.org/10.51821/89.3.15672

Vancouver

Rastogi A, Nagar N, Bihari C, Agrawal N, Maiwal R. Significance of Portal Tract Histological Changes in Metabolic Dysfunction-Associated Steatohepatitis. Acta Gastro-Enterologica Belgica. 2026. doi:10.51821/89.3.15672

BibTeX
@article{Rastogi2026,
  author = {Rastogi, A and Nagar, N and Bihari, C and Agrawal, N and Maiwal, R},
  title = {Significance of Portal Tract Histological Changes in Metabolic Dysfunction-Associated Steatohepatitis},
  journal = {Acta Gastro-Enterologica Belgica},
  year = {2026},
  doi = {10.51821/89.3.15672}
}
Kostenlos starten →